Trevena, Inc. TRVN
Regular-session close
- YTD
- -95.83%
- 1 year
- -95.83%
Discussion (68)
Happy Day! ?
Short ratio increase to 1.5 days vs .56 f try im last check. :)
Bargain Stock! Read article
Tramadol was approved in 1995 and has horrible serious side effects. What worries me is that i dont see insider buting or job openings. Anyone feels the same way?
It’s going to happen, like it or not, so don’t be shy and buy!
We need more pain medicine after this! Go TRVN!
On the downside, the stock finds support just below today's level from accumulated volume at $1.39 and $1.33.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Trevena finds support just below today's level at $1.39. If this is broken, then the next support from accumulated volume will be at $1.33 and $1.32.
Signs of life here?
Why is going down?
If the people buying the stock have more knowledge than the TRVN CEO ,on how to run a company, than we are pretty fuckeddd
